Narrowing the gap toward precision medicine for pancreatic cancer

January 19, 2018 by Laura Oleniacz, University of North Carolina at Chapel Hill School of Medicine

University of North Carolina Lineberger Comprehensive Cancer Center's Jen Jen Yeh, MD, is working to understand the complicated relationship between one of the deadliest cancers and the web of connective tissue that can surround the tumors.

In a new study, Yeh helped uncover findings about the role of the matrix of tissue called "" in , and in another, she helped identify the role of molecular subtypes in therapy response. Pancreatic cancer's five year survival rate is 8 percent in the United States, and researchers hope to improve that.

One of the challenges in treating pancreatic cancer is that while stroma can block treatment from reaching the tumor, Yeh said it may also prevent the tumor from spreading.

"As many elegant studies have found, stroma in pancreatic cancer is a double-edged sword – it can be both protective and promoting," said Yeh, who is a UNC Lineberger member, a professor in the UNC School of Medicine Division of Surgical Oncology and the vice chair for research in the Department of Surgery.

In a study in JCO Precision Oncology that Yeh co-led with Eric A. Collisson, MD, at the University of California, San Francisco, the researchers analyzed levels of stroma surrounding pancreatic cancer tumors, and in distant metastatic sites.

They found the primary tumors had a significantly higher stromal density than the cancer that had spread to solid organs. In addition, with a higher stromal density in their primary tumors had longer survival than other patients, a finding that can be analyzed using non-invasive methods, such as a CT scan.

Since they discovered that stroma is important to survival, Yeh said their findings suggest that physicians need to think before taking away the stroma on patients for whom their stroma is protective. That makes detecting stroma density at the outset particularly important.

"The vast majority of pancreatic cancer patients die with metastases, so therapies are targeted to metastatic disease," Yeh said. "The finding that different sites of pancreatic cancer have different amounts of stroma may have therapeutic implications, especially with the increasing interest in stroma-modulating therapies."

In a previous foundational study, Yeh characterized the biologic patterns in tumors and in stroma. She found that patients can have different biological or molecular types of tumors as well as stroma, and that both types are linked to outcomes. In a separate, recent Clinical Cancer Research study she co-authored, Yeh and colleagues, including those from the Princess Margaret Cancer Centre in Ontario, Canada, found that patients with one subtype of were more responsive to treatment than were patients with a different subtype.

"These studies emphasize the potential importance of individualizing therapies for specific tumor characteristics, and the need to develop ways to identify these characteristics with either biopsies or noninvasive imaging approaches," Yeh said.

Explore further: Pancreatic cancer subtypes discovered in largest gene expression analysis to date

More information: Robert J. Torphy et al. Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma, JCO Precision Oncology (2018). DOI: 10.1200/PO.17.00121

Related Stories

Pancreatic cancer subtypes discovered in largest gene expression analysis to date

September 9, 2015
Dense surrounding tissue can block drugs from reaching pancreatic cancer tumors, but it can also help prevent the cancer from spreading. Now a new study by UNC Lineberger Comprehensive Cancer Center researchers and collaborators ...

Eliminating cellular stroma could enable anti-cancer drugs to penetrate tumor tissues, improve survival

February 24, 2015
Like a stealth jet cloaks itself from radar, cancer cells cloak themselves within tumors by hiding behind a dense layer of cellular material known as stroma.

New insights on the addictions of tumors

October 6, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego have shown that tumors can ensure a more reliable nutrient supply by eliminating the p62 protein in surrounding stromal tissue. Specifically, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

Blocking enzyme in normal cells may impede pancreatic cancer, team shows

October 28, 2017
Cancer of the pancreas is a deadly disease, with a median survival time of less than six months. Only one in 20 people with pancreatic cancer survives five years past the diagnosis. The reason is the cancer's insidiousness; ...

A microRNA may provide therapy against pancreatic cancer

June 25, 2015
Indiana University cancer researchers found that a particular microRNA may be a potent therapeutic agent against pancreatic cancer. The research was published June 22 in the journal Scientific Reports.

Recommended for you

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas

May 18, 2018
Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas. In their report ...

Particle shows promise to prevent the spread of triple-negative breast cancer

May 18, 2018
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.

Dilemma for cancer patients as life-saving meds are tied to vision loss

May 18, 2018
(HealthDay)—A newer type of cancer treatment may offer the chance of longer survival, but the drugs could also trigger new side effects, such as vision problems.

Polygenic scores to classify cancer risk

May 18, 2018
Polygenic risk scores could be useful to stratify the risk of several cancers among patients in medical centers, allowing for the potential discovery of new associations between genes, disease and secondary effects, according ...

A way to prevent pancreatic cancer from spreading post-surgery?

May 17, 2018
Scientists at Cold Spring Harbor Laboratory (CSHL) have solved a mystery about how pancreatic cancer spreads following surgery in patients whose tumor is successfully removed. After surgery, patients' typically experience ...

Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

May 17, 2018
A new study suggests that a common treatment for erectile dysfunction combined with the flu vaccine may be able to help the immune system mop up cancer cells left behind after surgery. The study, published in OncoImmunology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.